{
    "N/R/U": null,
    "Applicant": "Iovance Biotherapeutics, Inc. ",
    "BLA Number": "125773",
    "Proprietary Name": "AMTAGVI",
    "Proper Name": "Lifileucel",
    "BLA Type": "351(a)",
    "Strength": "7.5x10^9 to 72x10^9Cells",
    "Dosage Form": "Suspension",
    "Route of Administration": "Intravenous",
    "Product Presentation": "Bag",
    "Marketing Status": "Rx",
    "Licensure": "Licensed",
    "Approval Date": "February 16, 2024",
    "Ref. Product Proper Name": null,
    "Ref. Product Proprietary Name": null,
    "Supplement Number": "0",
    "Submission Type": "Original",
    "License Number": "2298",
    "Product Number": "001",
    "Center": "CBER",
    "Date of First Licensure": "February 16, 2024",
    "Exclusivity Expiration Date": null,
    "First Interchangeable Exclusivity Exp. Date": null,
    "Ref. Product Exclusivity Exp. Date": "February 16, 2036",
    "Orphan Exclusivity Exp. Date": "February 16, 2031",
    "drug": [
        {
            "name": "Lifileucel",
            "drugbank_id": "https://go.drugbank.com/drugs/DB17107"
        }
    ]
}